Respiratory syncytial virus (RSV) research hub
6 indexed studies · 2 currently recruiting
- completed
Surveillance towards preventing RSV respiratory infection in paediatrics
This UK study looks at how common Respiratory Syncytial Virus (RSV) is in children under three years old. RSV often causes winter chest infections like bronchiolitis. By testing simple nose swabs and surveying parents, researchers want to measure the impact on families and the NHS to help design future vaccines.
United Kingdom · England - recruitingTherapeutic exploratory (Phase II)
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of EDP-938 in Non-hospitalized Adults with Acute Respiratory Syncytial Virus Infection who are at High Risk for Complications
This study is testing a new medicine, EDP-938, for adults with RSV who are well enough to be at home but are at higher risk of getting very sick. It aims to see if the medicine helps them recover faster from RSV symptoms like cough and breathlessness.
Slovakia · Spain · Poland - completedPhase II
Evaluate the efficacy, safety and dose-response of S-337395
This study tests a new medicine called S-337395 for treating Respiratory Syncytial Virus (RSV). Healthy volunteers aged 18-55 will be given RSV and then the study drug or a dummy drug to see if it works and is safe. The study takes place in London.
United Kingdom · England - recruitingPHASE1
A Study to Investigate Safety, Reactogenicity, and Immunogenicity of mRNA-1365 (Profile 2) in Older Healthy Adults
This study is testing new vaccine candidates, called mRNA-1365 and mRNA-1345, for illnesses like Respiratory Syncytial Virus (RSV) and Human Metapneumovirus (hMPV). Researchers want to see if these vaccines are safe, what side effects they might cause, and how well they help older healthy adults' immune systems fight off these viruses.
Canada · United Kingdom - active not recruiting
Understanding RSV: Severe Disease and the Long Term Consequences
This study looks at RSV, a common winter bug, in babies under 12 months. We want to understand why some babies get very sick and if RSV has long-term effects like wheezing. We're comparing babies with RSV to healthy babies, tracking their health over several years.
United Kingdom - authorisedTherapeutic confirmatory (Phase III)
Pregnancy and Infant PrEparedness pLatform IN Europe (PIPELINE)-RSV immunisation adaptive platform trial
Researchers are looking into new ways to protect babies from a common chest infection called RSV. This study is testing special medicines designed to prevent RSV in infants. It aims to see how well these work and keep babies healthy.
Belgium · Netherlands